These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37863311)

  • 1. Estimating the global impact of rotavirus vaccines on child mortality.
    Clark A; Mahmud S; Debellut F; Pecenka C; Jit M; Perin J; Tate J; Soeters HM; Black RE; Santosham M; Sanderson C
    Int J Infect Dis; 2023 Dec; 137():90-97. PubMed ID: 37863311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Removing the age restrictions for rotavirus vaccination: a benefit-risk modeling analysis.
    Patel MM; Clark AD; Sanderson CF; Tate J; Parashar UD
    PLoS Med; 2012; 9(10):e1001330. PubMed ID: 23109915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Nigeria.
    Anderson JD; Pecenka CJ; Bagamian KH; Rheingans RD
    PLoS One; 2020; 15(5):e0232941. PubMed ID: 32469927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global, Regional, and National Estimates of Rotavirus Mortality in Children <5 Years of Age, 2000-2013.
    Tate JE; Burton AH; Boschi-Pinto C; Parashar UD;
    Clin Infect Dis; 2016 May; 62 Suppl 2():S96-S105. PubMed ID: 27059362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimated public health impact of human rotavirus vaccine (HRV) and pneumococcal polysaccharide protein D-conjugate vaccine (PHiD-CV) on child morbidity and mortality in Gavi-supported countries.
    Marijam A; Schuerman L; Izurieta P; Pereira P; Van Oorschot D; Mehta S; Ota MO; Standaert B
    Hum Vaccin Immunother; 2022 Dec; 18(7):2135916. PubMed ID: 36507685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules.
    Clark A; Tate J; Parashar U; Jit M; Hasso-Agopsowicz M; Henschke N; Lopman B; Van Zandvoort K; Pecenka C; Fine P; Sanderson C
    Lancet Glob Health; 2019 Nov; 7(11):e1541-e1552. PubMed ID: 31607466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccines for preventing rotavirus diarrhoea: vaccines in use.
    Soares-Weiser K; Bergman H; Henschke N; Pitan F; Cunliffe N
    Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rotavirus Vaccination and the Global Burden of Rotavirus Diarrhea Among Children Younger Than 5 Years.
    Troeger C; Khalil IA; Rao PC; Cao S; Blacker BF; Ahmed T; Armah G; Bines JE; Brewer TG; Colombara DV; Kang G; Kirkpatrick BD; Kirkwood CD; Mwenda JM; Parashar UD; Petri WA; Riddle MS; Steele AD; Thompson RL; Walson JL; Sanders JW; Mokdad AH; Murray CJL; Hay SI; Reiner RC
    JAMA Pediatr; 2018 Oct; 172(10):958-965. PubMed ID: 30105384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimated impact of rotavirus vaccine on hospitalizations and deaths from rotavirus diarrhea among children <5 in Asia.
    Burnett E; Tate JE; Kirkwood CD; Nelson EAS; Santosham M; Steele AD; Parashar UD
    Expert Rev Vaccines; 2018 May; 17(5):453-460. PubMed ID: 29463143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis.
    Tate JE; Burton AH; Boschi-Pinto C; Steele AD; Duque J; Parashar UD;
    Lancet Infect Dis; 2012 Feb; 12(2):136-41. PubMed ID: 22030330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines for preventing rotavirus diarrhoea: vaccines in use.
    Soares-Weiser K; Bergman H; Henschke N; Pitan F; Cunliffe N
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD008521. PubMed ID: 30912133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of rotavirus vaccine on childhood diarrhea mortality in five Latin American countries.
    Paternina-Caicedo A; Parashar UD; Alvis-Guzmán N; De Oliveira LH; Castaño-Zuluaga A; Cotes-Cantillo K; Gamboa-Garay O; Coronell-Rodríguez W; De la Hoz-Restrepo F
    Vaccine; 2015 Jul; 33(32):3923-8. PubMed ID: 26116247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Pakistan.
    Rheingans R; Anderson JD; Bagamian KH; Laytner LA; Pecenka CJ; Gilani SSA; Ahmed M
    Vaccine; 2018 Dec; 36(51):7780-7789. PubMed ID: 30007826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of geographic and economic heterogeneity on rotavirus diarrhea burden and vaccination impact and cost-effectiveness in the Lao People's Democratic Republic.
    Rheingans R; Anderson JD; Bagamian KH; Pecenka CJ
    Vaccine; 2018 Dec; 36(51):7868-7877. PubMed ID: 30007827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global mortality associated with rotavirus disease among children in 2004.
    Parashar UD; Burton A; Lanata C; Boschi-Pinto C; Shibuya K; Steele D; Birmingham M; Glass RI
    J Infect Dis; 2009 Nov; 200 Suppl 1():S9-S15. PubMed ID: 19817620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Issues with reducing the rotavirus-associated mortality by vaccination in developing countries.
    Naghipour M; Nakagomi T; Nakagomi O
    Vaccine; 2008 Jun; 26(26):3236-41. PubMed ID: 18472196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimated impact and cost-effectiveness of rotavirus vaccination in Senegal: A country-led analysis.
    Diop A; Atherly D; Faye A; Lamine Sall F; Clark AD; Nadiel L; Yade B; Ndiaye M; Fafa Cissé M; Ba M
    Vaccine; 2015 May; 33 Suppl 1():A119-25. PubMed ID: 25919151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of rotavirus vaccination on acute diarrhea in Thai children under 5 years of age in the first year of universal implementation of rotavirus vaccines in the National Immunization Program (NIP) in Thailand: a 6-year analysis.
    Charoenwat B; Suwannaying K; Paibool W; Laoaroon N; Sutra S; Thepsuthammarat K; Sirirattanakul S
    BMC Public Health; 2023 Oct; 23(1):2109. PubMed ID: 37891542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global Estimates of Rotavirus Hospitalizations Among Children Below 5 Years in 2019 and Current and Projected Impacts of Rotavirus Vaccination.
    Hallowell BD; Chavers T; Parashar U; Tate JE
    J Pediatric Infect Dis Soc; 2022 Apr; 11(4):149-158. PubMed ID: 34904636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines for preventing rotavirus diarrhoea: vaccines in use.
    Soares-Weiser K; Maclehose H; Bergman H; Ben-Aharon I; Nagpal S; Goldberg E; Pitan F; Cunliffe N
    Cochrane Database Syst Rev; 2012 Nov; 11():CD008521. PubMed ID: 23152260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.